Healthcare -
Biotechnology - NASDAQ - US
$ 128.0
0.361 %
$ 6.24 B
Market Cap
-21.33
P/E
AXSM - OTHER CURRENT LIABILITIES
Other Current Liabilities AXSM - Axsome Therapeutics, Inc.
155 M
LAST VALUE
64.31%
2 YEAR CAGR
69.97%
5 YEAR CAGR
97.39%
10 YEAR CAGR